Category:
Other Excipients
CAS NO:
/
Standard:
In-house Standards,

"1, Primary dementia (Alzheimer's senile dementia); 2, Vascular dementia (eg multi-infarct dementia, etc) and cognitive dysfunction after mild and moderate stroke; 3, Mixed dementia; 4, Cerebral function disorders after cranial injuries." "1, Time to market: 2004 2, Our Market share in domestic China: No. 1 3, Exported countries: India, Viet Nam, Georgia; 4, Originator: Cerebrolysin® by Ebewe, Austria Registration Dossiers:non-clinical & clinical part, drug substance part and drug product part."